SCHEMBL5037842

SCHEMBL5037842

COC(=O)Nc1nc2c(OC)ccc(N)c2o1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGPAT2 O15120 1/20 0.39
ALDH1A1 P00352 6/20 0.38
TSHR P16473 4/20 0.38
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
HTT P42858 2/20 0.37
PKM P14618 2/20 0.37
KDM4E B2RXH2 4/20 0.36
HPGD P15428 4/20 0.36
HSD17B10 Q99714 3/20 0.36
MAPT P10636 2/20 0.36
LMNA P02545 3/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CA9 Q16790 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
NPC1 O15118 1/20 0.34
ESR1 P03372 1/20 0.34
TP53 P04637 1/20 0.34
RAB9A P51151 1/20 0.34
ESR2 Q92731 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5033935 0.84 ALDH1A1 (0.38) AGPAT2ALDH1A1TSHRADORA2AADORA1
SCHEMBL5036164 0.80 HTT (0.45) ALDH1A1TSHRADORA2AADORA1HTT
SCHEMBL5036203 0.78 ALDH1A1 (0.41) ALDH1A1ADORA2AADORA1HTTPKM
SCHEMBL5036100 0.76 ADORA2A (0.63) ALDH1A1TSHRADORA2AADORA1PKM
SCHEMBL5040838 0.75 NPC1 (0.44) AGPAT2ALDH1A1ADORA2AKDM4EHPGD
SCHEMBL5040888 0.75 RPS6KA2 (0.40) ALDH1A1TSHRHTTKDM4EHPGD
SCHEMBL5036067 0.74 ADORA2A (0.38) AGPAT2ALDH1A1TSHRADORA2AADORA1
SCHEMBL6868209 0.71 ALDH1A1 (0.59) ALDH1A1TSHRADORA2AADORA1PKM
SCHEMBL5037699 0.66 ADCY1 (0.51) ADORA2AADORA1HTTKDM4EHPGD
SCHEMBL13176003 0.64 SMN1; SMN2 (0.50) ALDH1A1TSHRHTTPKMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1587799-B1 BENZOXAZOLE DERIVATIVES AND THEIR USE AS ADENOSINE RECEPTOR LIGANDS HOFFMANN LA ROCHE (CH) 2008-03-12 EP disclosed
US-6992083-B2 deiodination/arylation, acylation or hydrogenation of a substituted 4-methoxy-bezoxazole derivative; adenosine receptor ligands; Parkinson's and Alzheimer's Diseases; 2-Chloromethyl-N-[7-(4-fluoro-phenyl)-4-methoxy-benzooxazol-2-yl]-isonicotinamide HOFFMAN-LA ROCHE INC. (US) 2006-01-31 US disclosed
EP-1587799-A1 BENZOXAZOLE DERIVATIVES AND THEIR USE AS ADENOSINE RECEPTOR LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 2005-10-26 EP disclosed
US-20040152702-A1 Benzoxazol derivatives F. HOFFMANN-LA ROCHE AG (CH) 2004-08-05 US disclosed
WO-2004063177-A1 BENZOXAZOLE DERIVATIVES AND THEIR USE AS ADENOSINE RECEPTOR LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 2004-07-29 WO disclosed
WO-2004063177-A1 BENZOXAZOLE DERIVATIVES AND THEIR USE AS ADENOSINE RECEPTOR LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 2004-07-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152702-A1 Benzoxazol derivatives P2RX3, P2RX2, P2RX1 AGPAT2 3126/4885ALDH1A1 1200/4885TSHR 167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.